apomorphine has been researched along with Experimental Neoplasms in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gurkalo, VK; Zabezhinskiĭ, MA | 1 |
| Cantin, M; Collu, R; Eljarmak, D; Lis, M; Marchisio, AM | 1 |
| Groshong, JC; Malarkey, WB; Milo, GE | 1 |
| Endo, T; Hojo, H; Imai, Y; Kondo, Y; Nozoe, S | 1 |
4 other study(ies) available for apomorphine and Experimental Neoplasms
| Article | Year |
|---|---|
[Effects of apomorphine and haloperidol on experimental hepatocarcinogenesis].
Topics: Adenoma; Adenoma, Bile Duct; Animals; Apomorphine; Cell Transformation, Neoplastic; Diethylnitrosamine; Haloperidol; Hemangioma; Liver Neoplasms; Liver Neoplasms, Experimental; Male; Neoplasms, Experimental; Rats; Receptors, Dopamine | 1983 |
Estrone-induced, prolactin-secreting and dopamine-sensitive rat pituitary tumor.
Topics: Animals; Apomorphine; Castration; Cells, Cultured; Dopamine; Estrone; Female; Neoplasms, Experimental; Pituitary Hormones; Pituitary Neoplasms; Prolactin; Rats; Rats, Inbred F344 | 1984 |
Defective dopaminergic regulation of prolactin secretion in a rat pituitary tumour cell line.
Topics: Apomorphine; Cell Line; Dopamine; Dose-Response Relationship, Drug; Neoplasms, Experimental; Pimozide; Pituitary Gland; Pituitary Neoplasms; Prolactin; Receptors, Dopamine | 1977 |
Suppression of tumor cell growth and mitogen response by aporphine alkaloids, dicentrine, glaucine, corydine, and apomorphine.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Antitussive Agents; Apomorphine; Aporphines; Cell Division; Colonic Neoplasms; Evaluation Studies as Topic; Immunosuppressive Agents; Leukemia L1210; Leukemia P388; Lymphocyte Activation; Male; Melanoma, Experimental; Mice; Mitogens; Neoplasms, Experimental; Urinary Bladder Neoplasms | 1990 |